MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
miRagen Therapeutics Appoints Kevin Koch, Ph.D., to Its Board of Directors.
Brennan CaruthersSeptember 9, 2016
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

miRagen Therapeutics and Signal Genetics Sign Merger Agreement.

Brennan CaruthersOctober 31, 2016
Next

F‐star Announces Collaborative Agreement with Denali Therapeutics for the Development of a Multispecific Antibody Platform to Deliver Therapeutics Across the Blood‐Brain Barrier.

Brennan CaruthersAugust 25, 2016

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact